Endocrine Disruptors: State of the Issue in the Regulatory Framework of the European Union

被引:0
|
作者
Gonzalez Marquez, Maria Luisa [1 ]
Ordonez Iriarte, Jose Maria [2 ,3 ]
Cabello Dieguez, Covadonga [1 ]
机构
[1] Minist Sanidad Consumo & Bienestar Social, Subdirecc Gen Sanidad Ambiental & Salud Laboral, Paseo Prado 18-20, Madrid 28071, Spain
[2] Consejeria Sanidad Comunidad Madrid, Subdirecc Gen Sanidad Ambiental, Madrid, Spain
[3] Univ Francisco de Vitoria, Dept Salud Publ, Madrid, Spain
关键词
endocrine disruptor; chemicals; biocides; plant protection products; CHEMICALS; PRINCIPLES;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This article reviews the historical evolution of the knowledge and regulation on endocrine disruptors, highlighting the main elements of the debate that has taken place around them and the measures that have been adopted in the European Union until the current situation has been reached.
引用
收藏
页码:86 / 94
页数:9
相关论文
共 50 条
  • [41] Recognition of Debt Restructuring and Resolution Measures under the European Union Regulatory Framework
    Arons, Tomas
    INTERNATIONAL INSOLVENCY REVIEW, 2014, 23 (01) : 57 - 72
  • [42] Towards a future regulatory framework for chemicals in the European Union-Chemicals 2.0
    Berggren, Elisabet
    Worth, Andrew P.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2023, 142
  • [43] Cancer Drug Development and the Evolving Regulatory Framework for Companion Diagnostics in the European Union
    Pignatti, Francesco
    Ehmann, Falk
    Hemmings, Robert
    Jonsson, Bertil
    Nuebling, Micha
    Papaluca-Amati, Marisa
    Posch, Martin
    Rasi, Guido
    CLINICAL CANCER RESEARCH, 2014, 20 (06) : 1458 - 1468
  • [44] THE EUROPEAN OMBUDSMAN IN THE FRAMEWORK OF THE EUROPEAN UNION
    Moure Pino, Ana Maria
    REVISTA CHILENA DE DERECHO, 2011, 38 (03): : 421 - 455
  • [45] Regulatory application of SAR/QSAR for priority setting of endocrine disruptors: A perspective
    Tong, WD
    Fang, H
    Hong, HX
    Xie, Q
    Perkins, R
    Anson, J
    Sheehan, DM
    PURE AND APPLIED CHEMISTRY, 2003, 75 (11-12) : 2375 - 2388
  • [46] Regulatory Testing for Endocrine Disruptors; Need for Validated Methods and Integrated Approaches
    Grignard, Elise
    de Jesus, Kelly
    Hubert, Philippe
    FRONTIERS IN TOXICOLOGY, 2022, 3
  • [47] Diversity, equity, and inclusion reporting in European Union companies: The role of female directors and the European regulatory framework
    Garcia-Sanchez, Isabel-Maria
    Marin-Hernandez, Salvador
    Ortiz-Martinez, Esther
    Aibar-Guzman, Beatriz
    BUSINESS STRATEGY AND THE ENVIRONMENT, 2024,
  • [48] Phytosterols act as endocrine and metabolic disruptors in the European polecat (Mustela putorius)
    Nieminen, P
    Mustonen, AM
    Lindström-Seppä, P
    Asikainen, J
    Mussalo-Rauhamaa, H
    Kukkonen, JVK
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2002, 178 (01) : 22 - 28
  • [49] Endocrine Disruptors and Water Quality: A State-of-the-Art Review
    Burkhardt-Holm, Patricia
    INTERNATIONAL JOURNAL OF WATER RESOURCES DEVELOPMENT, 2010, 26 (03) : 477 - 493
  • [50] A modeling framework for exploring the population-level effects of endocrine disruptors
    McTavish, K
    Stech, H
    Stay, F
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 1998, 17 (01) : 58 - 67